Focus Oncotherapies #7


January 29, 2021

Focus Oncotherapies #7

Personalized medicine takes another step towards colon cancer prevention.

A recently published study highlighted the link between the intestinal microbiota and the risk of developing cancer, demonstrating how, in a genetically predisposed subject, intestinal bacteria can make the difference between developing colon cancer or not.

This means that the intestinal microbiota must be studied both as a risk factor and as an element on which to act for prevention.

Read full article